You Position: Home > Paper
Viral vaccines associated with dermatoses and venereal diseases
( views:0, downloads:0 )
- Author:
- No author available
- Journal Title:
- INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.1673-4173.2010.05.015
- Key Word:
- 乳头瘤病毒疫苗;带状疱疹疫苗;HIV;单纯疱疹病毒属;疫苗;Papillomavirus vaccines;Herpes zoster vaccine;HIV;Simplex virus;Vaccine
Abstract： Progress has been made in the research of vaccines against human papillomavirus (HPV),herpes zoster virus (HZV), human immunodeficiency virus (HIV) and herpes simplex virus (HSV), which will benefit the prevention of some dermatoses and venereal diseases, and reduce the healthcare burden associated with diseases caused by the four viruses. This review describes recent advances in studies on efficacy and safety of vaccines against HPV and HZV, and in development of vaccines against HIV and HSV.
- [1]中国科学院生命科学和医学学部.关于我国艾滋病疫苗研发策略的建议[J].2006,(5).
- [2]Cardin, Rhonda,Earwood, Julie,Farley, Nicholas,etc.The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs[J].2010,28(21).
- [3]Weinberg A,Zhang JH,Oxman MN.Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.[J].2009,200(7).
- [4]Klara Velinzon,Niklas Feldhahn,et al,etc.Broad Diversity Of Neutralizing Antibodies Isolated From Memory B Cells In Hiv-infected Individuals[J].2009,458(Apr.2 TN.7238).
- [5]Oxman MN,Straus SE,Simberkoff MS,etc.A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.[J].2005,352(22).
- [6]Barrasso R,Walboomers JM,Wettendorff M,etc.Randomized Controlled Trial of an Adjuvanted Human Papillomavirus (HPV) Type 6 L2E7 Vaccine: Infection of External Anogenital Warts with Multiple HPV Types and Failure of Therapeutic Vaccination.[J].2005,192(12).
- [7]Gnann-JW Jr.Vaccination to prevent herpes zoster in older adults.[J].2008,9(1 Suppl.1).
- [8]Margaret Stanley.Prophylactic HPV vaccines[J].2007,60(9).
- [9]Parsania M,Hassan ZM,Bamdad T,etc.Evaluation of apoptotic and anti-apoptotic genes on efficacy of DNA vaccine encoding glycoprotein B of Herpes Simplex Virus type 1.[J].2010,128(2).
- [10]Smith JG,Keller PM,Levin MJ,etc.Decline in Varicella-Zoster Virus (VZV)-Specific Cell-Mediated Immunity with Increasing Age and Boosting with a High-Dose VZV Vaccine.[J].2003,188(9).
- [11]Dürdal, Us.[Herpes simplex virus vaccine studies: from past to present].[J].2006,40(4).
- [12]Greenacre M.Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.[J].2009,374(9686).
- [13]Munoz N,Manalastas R Jr,Pitisuttithum P,etc.Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.[J].2009,373(9679).
- [14].Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection.[J].2007,196(10).
- [15].Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.[J].2007,356(19).